Diabetes Core Update December 2022 | American Diabetes Association
Podcast Type: 
Diabetes Core
Publication Date: 
Friday, November 25, 2022 - 00:00
Neil S. Skolnik, MD and John J. Russell, MD

Post Date: November 25, 2022
Total Time: 29:38 | File Size: 41 MB

Articles Covered in this Edition

Empagliflozin in Patients with Chronic Kidney Disease. The EMPA-KIDNEY Collaborative Group. N Engl J Med November 4, 2022. https://doi.org/10.1056/NEJMoa2204233.

Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease. Lamprea-Montealegre et al. Diabetes Care 2022;45(12):2900–2906. https://doi.org/10.2337/dc22-0614.

Relationship Between Carbohydrate Intake (Quantity, Quality, and Time Eaten) and Mortality (Total, Cardiovascular, and Diabetes): Assessment of 2003–2014 National Health and Nutrition Examination Survey Participants. Hou et al. Diabetes Care 2022;45(12):3024–3031. https://doi.org/10.2337/dc22-0462.

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). de Boer et al. Diabetes Care 2022;45(12):3075–3090. https://doi.org/10.2337/dci22-0027.

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Rossing et al. Diabetes Care 2022;45(12):2991–2998. https://doi.org/10.2337/dc22-0294.

Effects of a Low-Carbohydrate Dietary Intervention on Hemoglobin A1c: A Randomized Clinical Trial. Dorans et al. JAMA Netw Open 2022;5(10):e2238645. https://doi.org/10.1001/jamanetworkopen.2022.38645.

For more information about each of ADA’s science and medical journals, please visit diabetesjournals.org.